Muthusamy Shanmugam, HEAD OF R&D, COO-NOVITIUM Operations at ANI PHARMACEUTICALS INC (ANIP), sold 50,000 shares at $57.58 ($2.9M) on 2023-10-13, disclosed to the SEC on 2023-10-17.
Scheduled sale ($2.9M) by HEAD OF R&D, COO-NOVITIUM Operations under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $57.58 | 11,937 | $687K | 23.7% |
| 2 | $57.58 | 11,937 | $687K | 23.7% |
| 3 | $58.31 | 13,063 | $762K | 26.3% |
| 4 | $58.31 | 13,063 | $762K | 26.3% |
| Total | $57.96 avg | 50,000 | $2.9M | 100% |
| Filing → |
| ANIP | SELL | 2025-05-13 | $54K | — | Filing → |
| ANIP | SELL | 2024-07-19 | $170K | — | Filing → |
| ANIP | SELL | 2024-07-17 | $3.9M | — | Filing → |